Stage I Multiple Myeloma Treatment
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Stage I Multiple Myeloma Treatment is a clinical trial[1].
Key Facts
- Stage I Multiple Myeloma Treatment is in the country of France[2].
- Stage I Multiple Myeloma Treatment's instance of is recorded as clinical trial[3].
- Stage I Multiple Myeloma Treatment's start time is recorded as +2004-12-31T00:00:00Z[4].
- Stage I Multiple Myeloma Treatment's end time is recorded as +2009-11-30T00:00:00Z[5].
- Stage I Multiple Myeloma Treatment's sponsor is recorded as Centre Hospitalier Universitaire de Nice[6].
- Stage I Multiple Myeloma Treatment's main subject is recorded as multiple myeloma[7].
- Stage I Multiple Myeloma Treatment's number of participants is recorded as {'unit': '1', 'amount': '+350'}[8].
- Stage I Multiple Myeloma Treatment's title is recorded as Stage I Multiple Myeloma Treatment[9].
- Stage I Multiple Myeloma Treatment's short name is recorded as IFM-01-04[10].
- Stage I Multiple Myeloma Treatment's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[11].
- Stage I Multiple Myeloma Treatment's ClinicalTrials.gov ID is recorded as NCT00733538[12].
- Stage I Multiple Myeloma Treatment's research intervention is recorded as zoledronic acid[13].
- Stage I Multiple Myeloma Treatment's clinical trial phase is recorded as phase IV clinical trial[14].
- Stage I Multiple Myeloma Treatment's research subject recruitment status is recorded as Coronavirus[15].
- Stage I Multiple Myeloma Treatment's study type is recorded as interventional study[16].